Medicine & Life Sciences
Multiple Sclerosis
100%
Sunphenon
42%
siponimod
36%
masitinib
35%
ocrelizumab
33%
Sphingosine 1 Phosphate Receptor Modulators
32%
idebenone
31%
Riluzole
28%
Oxcarbazepine
27%
Natalizumab
27%
Domperidone
26%
Receptor-Interacting Protein Serine-Threonine Kinases
26%
Drug Repositioning
25%
Thioctic Acid
25%
Immunoglobulin Domains
24%
epigallocatechin gallate
24%
Dopamine Antagonists
23%
Phosphodiesterase Inhibitors
23%
Amiloride
22%
Subunit Vaccines
22%
Fluoxetine
21%
Neuronal Outgrowth
21%
Biotin
20%
Rituximab
20%
Lithium
20%
Erythropoietin
19%
Leucine
19%
T-Cell Antigen Receptor
19%
Neuroprotective Agents
19%
Adrenocorticotropic Hormone
18%
Therapeutics
18%
Hydroxymethylglutaryl-CoA Reductase Inhibitors
18%
Cell- and Tissue-Based Therapy
17%
Protein-Tyrosine Kinases
17%
Immunotherapy
16%
Disease Progression
15%
Antioxidants
13%
Stem Cells
13%
Monoclonal Antibodies
13%
Hormones
13%
Clinical Trials
12%
T-Lymphocytes
11%